B3GAT1 and plasma cell myeloma: Therefore, we assessed surface expression of PD-1, CTLA-4, CD160, and 2B4, as well as expression of CD57 and CD28 in myeloma CD8+ T cells before and after therapy with immunomodulatory drugs and dexamethasone.